ArticleCancers2023

L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells.

Yoonki Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.